ESC 365 - Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Open Access

Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Session: Impact of Colchicine on Cardiovascular Disease

Topic: Pharmacotherapy

Speaker: Doctor N. Bouabdallaoui (Montreal, CA)

Event: ESC CONGRESS 2020 - The Digital Experience

Congress Session

About the speaker

Doctor Nadia Bouabdallaoui

Montreal Heart Institute, Montreal (Canada)

1 presentation

0 follower

3 more presentations in this session

Online Session - Impact of Colchicine on Cardiovascular Disease - Host and discussant

Speaker: Professor M. Imazio (Udine, IT)

COLCOT Pharmacogenomics

Speaker: Professor M. Dube (Montreal, CA)

COPS Trial - Colchicine to Improve Cardiovascular Outcomes in ACS Patients

Speaker: Doctor J. Layland (Melbourne, AU)

Access the full session

Impact of Colchicine on Cardiovascular Disease

Speakers: Doctor N. Bouabdallaoui, Professor M. Imazio, Professor M. Dube, Doctor J. Layland

About the event

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Congress

Related content

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

Open Access

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

27 August 2021

Open Access

Colchicine in Acute Myocardial Infarction

27 August 2021

This platform is supported by